Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis
- 30 April 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 38 (4), 434-440
- https://doi.org/10.1016/s0168-8278(03)00027-8
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of diseaseAmerican Journal of Gastroenterology, 2001
- Insulin resistance in non-alcoholic steatohepatitisDigestive and Liver Disease, 2001
- Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalitiesGastroenterology, 2001
- Association of nonalcoholic fatty liver disease with insulin resistanceThe American Journal of Medicine, 1999
- Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitisJournal of Hepatology, 1999
- Liver Pathology and the Metabolic Syndrome X in Severe ObesityJournal of Clinical Endocrinology & Metabolism, 1999
- Fatty liveran additional and treatable feature of the insulin resistance syndromeQJM: An International Journal of Medicine, 1999
- The Relationship Between Fatty Liver and Hyperinsulinemia in Obese Japanese ChildrenJournal of Pediatric Gastroenterology and Nutrition, 1997
- Hepatic subcapsular steatosis in a patient with insulin dependent diabetes receiving dialysis.Journal of Clinical Pathology, 1994
- Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factorsHepatology, 1990